Articles

TOTAL trial, thrombectomy, STEMI

Clearing blood clots (thrombectomy) from coronary arteries in about 20 percent of patients undergoing angioplasty...

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to...

radiation, risk, cancer patients, information, Memorial Sloan Kettering, MSKCC

A new study published online in the journal Radiology found a substantial gap between patient expectations and current practices for providing information about medical imaging tests that...

Patients over age 80 with acute coronary syndromes would likely benefit from more invasive tests and therapies that may otherwise be denied them due to their age, according to research presented...

atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two coprimary endpoints — a composite...

low-dose radiation, cancer risk, mice, Berkeley National Laboratory, therapy, CT

Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory  have uncovered new clues about the risk of cancer from low-dose radiation. In this research, low-dose is...

cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy

AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain management. AtriCure’s cryoICE is the...

heart failure, BAT, baroreflex activation therapy, William Abraham, CVRx

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart...

Mitralign, transcatheter triscupid repair, TTVR, TR, first in human

A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department...

Mitraclip, abbott, mitral valve repair, ACC, transcatheter mitral valve repair

The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S....